findmyKOL

Jonathan Coblyn, MD

Basic profile

Brigham and Women's Hospital

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Jonathan Coblyn is a Rheumatology/Immunology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 239 publications with 10,438 citations (h-index 24).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
239publications

Distinct works indexed by OpenAlex, matched via ORCID.

10,438citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

75 Francis Street Pbb B3
Brigham And Women'S Hospital Dept Of Rheumatology Immun
Boston, MA 02115

Telephone

617-732-5347

Provider last certified this registry record 7 Dec 2020.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    46.8%
    TNF inhibitor18.3%
    Enbrel Sureclick48%Enbrel15%Humira Pen14%Humira(Cf)10%Humira6%Humira(Cf) Pen6%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor12.4%
    Methotrexate93%Methotrexate Sodium7%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    20.5%
    Corticosteroid14.8%
    Prednisone100%
    Part D75 patients
    Proton pump inhibitor3%
    Omeprazole100%
    Part D13 patients

    + 2 more classes in this area

  • Nervous system

    11.4%
    Opioid Agonist4.7%
    Oxycodone Hcl79%Tramadol Hcl21%
    Part D<11 patients
    Gabapentinoids1.9%
    Gabapentin100%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”